# Comparing the Pharmacological Profile of Formulations Containing Omega 3 Fatty Acids

> **NCT05394701** · NA · COMPLETED · sponsor: **Factors Group of Nutritional Companies Inc.** · enrollment: 12 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 LipoMicel® soft gels
- **DIETARY_SUPPLEMENT:** RxOmega-3 soft gels (Enteric)
- **DIETARY_SUPPLEMENT:** Omega-3 Complete soft gels (Non-Enteric)

## Key facts

- **NCT ID:** NCT05394701
- **Lead sponsor:** Factors Group of Nutritional Companies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05394701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05394701, "Comparing the Pharmacological Profile of Formulations Containing Omega 3 Fatty Acids". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05394701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*